Comparison of different criteria for interpretation of immunoglobulin G immunoblotting results for diagnosis of Helicobacter pylori infection.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 404564)

Published in Clin Diagn Lab Immunol on May 01, 2004

Authors

Philipp M Lepper1, Angelika Möricke, Konstanze Vogt, Günter Bode, Matthias Trautmann

Author Affiliations

1: Department of Internal Medicine II, University of Ulm, Robert-Koch-Str. 8, 89081 Ulm, Germany. philipp.lepper@medizin.uni-ulm.de

Articles cited by this

Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis (1990) 6.90

Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet (1987) 5.02

Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut (1997) 4.70

Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet (1992) 4.54

Purification and characterization of urease from Helicobacter pylori. J Biol Chem (1990) 4.22

Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol (1989) 3.73

Molecular identification of surface protein antigens of Campylobacter jejuni. Infect Immun (1983) 3.61

Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences. Ann Intern Med (1997) 2.60

Did the inheritance of a pathogenicity island modify the virulence of Helicobacter pylori? Trends Microbiol (1997) 2.33

Identification of the outer membrane proteins of Campylobacter pyloridis and antigenic cross-reactivity between C. pyloridis and C. jejuni. J Gen Microbiol (1987) 2.26

Seroconversion for Helicobacter pylori. Lancet (1993) 1.88

Identification and purification of a cpn60 heat shock protein homolog from Helicobacter pylori. Infect Immun (1992) 1.87

Detection of Campylobacter pyloridis in patients with antrum gastritis and peptic ulcers by culture, complement fixation test, and immunoblot. J Clin Microbiol (1986) 1.85

Urease-associated heat shock protein of Helicobacter pylori. Infect Immun (1992) 1.71

Serum IgG antibody to the outer membrane proteins of Campylobacter pylori in children with gastroduodenal disease. J Infect Dis (1989) 1.45

Immunoblot analysis of immune response to Campylobacter pylori and its clinical associations. J Clin Pathol (1988) 1.41

Immunoglobulin G antibodies to Helicobacter pylori in patients with dyspeptic symptoms investigated by the western immunoblot technique. J Clin Microbiol (1992) 1.39

Seroepidemiology of Helicobacter pylori infection in a cohort of children monitored from 6 months to 11 years of age. J Clin Microbiol (1997) 1.38

Identification of Helicobacter pylori by immunological dot blot method based on reaction of a species-specific monoclonal antibody with a surface-exposed protein. J Clin Microbiol (1995) 1.35

Seroprevalence of CagA-positive strains among Helicobacter pylori-infected, healthy young adults. J Infect Dis (1997) 1.34

Serodiagnosis of Helicobacter pylori infection in childhood. J Clin Microbiol (1990) 1.31

Helicobacter pylori infection in healthy people: a dynamic process? Gut (1991) 1.31

The reliability of urease tests, histology and culture in the diagnosis of Campylobacter pylori infection. Scand J Gastroenterol Suppl (1989) 1.23

Immunoblot assay for serodiagnosis of Helicobacter pylori infections. J Clin Microbiol (1997) 1.22

Demonstration of a flagellar antigen shared by a diverse group of spiral-shaped bacteria that colonize intestinal mucus. Infect Immun (1987) 1.19

IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer (1996) 1.16

Detection of antibodies to Helicobacter pylori cell surface antigens. Scand J Infect Dis (1990) 1.12

Clostridium perfringens urease genes are plasmid borne. Infect Immun (1997) 1.06

Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy. J Infect Dis (1993) 1.05

Effect of antimicrobial therapy on the specific serological response to Helicobacter pylori infection. Eur J Clin Microbiol Infect Dis (1992) 1.03

In vitro susceptibility of Helicobacter pylori to several antimicrobial combinations. Antimicrob Agents Chemother (1993) 1.02

Characterization of an immunoreactive species-specific 19-kilodalton outer membrane protein from Helicobacter pylori by using a monoclonal antibody. J Clin Microbiol (1991) 1.00

Use of a receiver operating characteristic in the evaluation of two commercial enzyme immunoassays for detection of Helicobacter pylori infection. Eur J Clin Microbiol Infect Dis (1994) 0.98

Cell surface proteins of Helicobacter pylori as antigens in an ELISA and a comparison with three commercial ELISA. Scand J Infect Dis (1992) 0.97

An assessment of serological tests for detection of Helicobacter pylori. Eur J Clin Microbiol Infect Dis (1992) 0.94

Humoral immune response against Helicobacter pylori as determined by immunoblot. Electrophoresis (1993) 0.93

Serodiagnosis of Helicobacter pylori-associated gastritis with a monoclonal antibody competitive enzyme-linked immunosorbent assay. Scand J Gastroenterol (1992) 0.91

Serodiagnosis of Helicobacter pylori infections by detection of immunoglobulin G antibodies using an immunoblot technique and enzyme immunoassay. Eur J Clin Microbiol Infect Dis (1992) 0.90

Detection of Helicobacter pylori in stomach tissue by use of a monoclonal antibody. J Clin Microbiol (1991) 0.89

Helicobacter pylori: when to test, when to treat. Ann Intern Med (1997) 0.81

Articles by these authors

Analysis of transmission pathways of Pseudomonas aeruginosa between patients and tap water outlets. Crit Care Med (2002) 1.82

Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics (2002) 1.63

Prevalence of Helicobacter pylori in the adolescent oral cavity: dependence on orthodontic therapy, oral flora and hygiene. J Orofac Orthop (2011) 1.55

Characteristics of infection with Candida species in patients with necrotizing pancreatitis. World J Surg (2001) 1.33

Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2002) 1.18

Risk of gastric cancer among smokers infected with Helicobacter pylori. Int J Cancer (2002) 1.01

Role of Helicobacter pylori infection in iron deficiency during pregnancy. Am J Obstet Gynecol (2005) 0.84

Role of Lewis A and Lewis B blood group antigens in Helicobacter pylori infection. Helicobacter (2004) 0.84

K-antigen-specific, but not O-antigen-specific natural human serum antibodies promote phagocytosis of Klebsiella pneumoniae. FEMS Immunol Med Microbiol (2003) 0.84

Helicobacter pylori-specific immune response in maternal serum, cord blood, and human milk among mothers with and without current Helicobacter pylori infection. Pediatr Res (2005) 0.83

Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease. Int J Med Microbiol (2006) 0.81

Octenidine in combination with polymethylmethacrylate: a new option for preventing infection? Arch Orthop Trauma Surg (2011) 0.77

Different acute-phase response in newborns and infants undergoing surgery. Pediatr Res (2002) 0.76

Meeting summary: possibilities for active and passive vaccination against opportunistic infections. Vaccine (2004) 0.75

[Therapy of diffuse suppurative peritonitis with continuous peritoneal lavage]. Wien Klin Wochenschr (2002) 0.75

[Diarrhea due to EHEC pathogens: characteristics in childhood]. Kinderkrankenschwester (2011) 0.75

[Antibiotics in premature rupture of fetal membranes: is there a benefit for the newborn infant?]. Kinderkrankenschwester (2011) 0.75

[Tick bites, Lyme disease and early summer meningoencephalitis. Current indications concerning infection risks, prevention and therapy]. Kinderkrankenschwester (2007) 0.75

[Influenza in children: what should be considered in prevention and treatment?]. Kinderkrankenschwester (2008) 0.75

[ESBL (extended spectrum β-lactamase) pathogens in the newborn unit: harmless colonizing bacteria or mortal threat?]. Kinderkrankenschwester (2012) 0.75

[Prevention of ventilator-associated pneumonia: what has changed due to the new Robert Koch Institute guideline? (interview by Hardy-Thorsten Panknin)]. Kinderkrankenschwester (2014) 0.75

[Circumcision and sexually transmitted infections: is a preventive effect assured?]. Kinderkrankenschwester (2009) 0.75

[Antimicrobial venous catheter: clinical effect only in brief implantation?]. Kinderkrankenschwester (2009) 0.75